发明名称 NOVEL COMPOUNDS
摘要 The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.
申请公布号 US2015080369(A1) 申请公布日期 2015.03.19
申请号 US201314394105 申请日期 2013.04.25
申请人 Glaxo Group Limited 发明人 Birault Veronique;Campbell Amanda Jennifer;Harrison Stephen;Le Joelle;Shukla Lena
分类号 C07C317/22;C07D295/135;C07D211/28;C07D265/30;C07D205/04;C07D309/06;C07D307/14;C07D305/06;C07D491/044;C07D207/09 主分类号 C07C317/22
代理机构 代理人
主权项 1. A compound of formula (Ia), or a pharmaceutically acceptable salt thereof: wherein R1 is selected from the group consisting of H, C1-3alkyl, C1-3alkoxy, CF3, and halo; R2, R3 and R4 are H; R5 is C1-3alkyl; R6 is C3-5alkyl or —CH2C3-4cycloalkyl; R7 is selected from the group consisting of: each R8 is independently selected from the group consisting of halo, C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, CN, OH, C(O)OH, C(O)OC1-3alkyl and CH2OH; R9 is the group —(CHR10)s—(X)t—(CHR10)u—R11; each R10 is independently selected from H, CH3, OH and CH2OH; X is CH2, NH or O; R11 is a heterocycloalkyl or C3-6cycloalkyl group which may be unsubstituted or substituted with one or more substituents independently selected from the group consisting of CH3, OMe, OH, CH2OH and halo; r is 0, 1 or 2; s is 0, 1 or 2; t is 0 or 1; u is 0, 1 or 2; with the proviso that no more than two R10 groups represent CH3, OH or CH2OH.
地址 Brentford, Middlesex GB
您可能感兴趣的专利